Mobile Clinic - a Cross-sectional Epidemiological Survey
NCT ID: NCT02055612
Last Updated: 2017-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3278 participants
OBSERVATIONAL
2013-03-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration
NCT01174407
Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment
NCT02381730
Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration
NCT05593913
Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)
NCT00417846
Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients With Unilateral Choroidal Neovascularisation
NCT00808197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Patients will fill a questionnaire with demography data, anamnesis, risk factors.
2. Patients will be assessed by using Amsler grid.
3. Patient´s back of the eye will be examined with fundus camera (searching for long-term back of the eye changes, retina vessels, macula and surrounding tissues) by retina specialist.
4. Patient undergoes optical coherent tomography (OCT) examination (cross-section of fovea and macula) by retina specialist.
The project actively screen patients with wAMD. All patients will sign an informed consent.
The process of screening will be held in certain timeframe (cca. 2 months) and selected areas of Slovak Republic.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with home base far than 35 km from the nearest center (centers: Bratislava, Nitra, Nové Zámky, Trenčín, Bojnice, Žilina, Martin, Ružomberok, Banská Bystrica, Zvolen, Poprad, Prešov, Košice, Trebišov)
3. Patient´s informed consent signed.
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Slovakia, s.r.o.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vladimir Krasnik, M.D., PhD.
Role: PRINCIPAL_INVESTIGATOR
Ophthalmology Clinic of Faculty of Medicine of Comenius University and Bratislava University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novartis Slovakia, s.r.o.
Bratislava, , Slovakia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRFB002ASK01 EPI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.